UNIGE document Scientific Article
previous document  unige:21176  next document
add to browser collection

Adverse effects of drugs in the treatment of viral hepatitis

Published in Best Practice & Research: Clinical Gastroenterology. 2010, vol. 24, no. 2, p. 183-192
Abstract The hepatitis B virus (HBV) and the hepatitis C virus (HCV) affect approximately 400-500 million individuals worldwide. Both infections are characterised by a significant morbidity and mortality: chronic hepatitis B and C may evolve towards the development of cirrhosis and primary hepatocellular carcinoma. During the last two decades, several new antivirals have been developed that are active against HBV and HCV, allowing sustained cure rates in a significant proportion of patients. All these drugs have side effects, which may represent a major barrier to achieve cure in many patients in need. I will review the most common adverse events reported during the therapy of chronic hepatitis B and C, with some recommendations for proper management.
Keywords Antiviral Agents/*adverse effectsDrugs, Investigational/*adverse effectsHepatitis B, Chronic/*drug therapyHepatitis C, Chronic/*drug therapyHumansInterferon-alpha/adverse effectsRibavirin/adverse effectsRisk AssessmentRisk Factors
PMID: 20227031
Full text
Research group Etudes et traitement de l'hépatite C et B (554)
(ISO format)
NEGRO, Francesco. Adverse effects of drugs in the treatment of viral hepatitis. In: Best Practice & Research: Clinical Gastroenterology, 2010, vol. 24, n° 2, p. 183-192. doi: 10.1016/j.bpg.2009.10.012 https://archive-ouverte.unige.ch/unige:21176

413 hits

0 download


Deposited on : 2012-05-23

Export document
Format :
Citation style :